Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Planned sale President sold 18,023 shares at $61.96 ($1,116,705)
  2. 4 Open-market buy 10% owner bought 60,431,039 shares at $0.95 ($57,409,487)
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 546 shares (to pay taxes)
  4. 4 Planned sale Director sold 4,090 shares at an average $64.06 ($262,005)
  5. 4 Shares withheld for taxes CFO and Treasurer gave up 35,730 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Business Officer gave up 25,574 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Accounting Officer gave up 6,360 shares (to pay taxes)
  8. 4 Shares withheld for taxes President gave up 20,728 shares (to pay taxes)
  9. 4 Shares withheld for taxes See Remarks gave up 8,457 shares (to pay taxes)
  10. 4 Open-market sale Director sold 22,389 shares at an average $65.42 ($1,464,749)
  11. 4 Grant or award CFO and Treasurer acquired 66,309 shares (grant or award)
  12. 4 Planned sale Director sold 93,863 shares at an average $65.31 ($6,129,889)
  13. 4 Grant or award President acquired 53,457 shares (grant or award)
  14. 4 Grant or award Chief Business Officer acquired 52,971 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 18,564 shares (grant or award)
  16. 4 Grant or award See Remarks acquired 36,922 shares (grant or award)
  17. 4 Grant or award CEO acquired 131,496 shares (grant or award)
  18. 4 Grant or award Chief Accounting Officer acquired 11,502 shares (grant or award)
  19. 4 Planned sale Chief Accounting Officer sold 341 shares at $55.31 ($18,861)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 30 · 598 filings